Immunoproteasomes containing the IFN-inducible subunits b1i (LMP2), b2i (MECL-1) and b5i (LMP7) alter proteasomal cleavage preference and optimize the generation of peptide ligands of MHC class I molecules. Here, we report on an unexpected new function of immunoproteasome subunits for the survival and expansion of CD4 1 and CD8 1 T cells during viral infection of mice. The effect of immunoproteasome subunit deficiency on T-cell survival upon adoptive transfer was most prominent for the lack of LMP7 followed by MECL-1 and LMP2. The survival of T cells in uninfected mice or the homeostatic expansion after transfer into RAG-2 À/À mice was not affected by the lack of the immu-
Introduction
The proteasome core complex, referred to as 20S proteasome, is a cylinder-shaped structure consisting of 28 subunits, arranged in four stacked rings. The two outer rings, each made up of seven a-type subunits (a 1 -a 7 ) are framing the two inner rings, each composed of seven b-type subunits (b 1 -b 7 ). The catalytic activity is performed by three b-subunits of each inner ring: b1 (d), b2 (MC14) and b5 (MB1). In the course of an immune response, the constitutive b-subunits are replaced in newly assembled proteasomes by the IFN-g-and TNF-a-inducible subunits b1i (LMP2), b5i (LMP7) and b2i (MECL-1) [1] , thereby building so-called immunoproteasomes [2] . Immunoproteasomes cleave Ag with a different cleavage preference [3, 4] , thus optimizing the quantity and quality of the generated peptides for presentation by MHC class I molecules [5] [6] [7] [8] .
In the previous experiments, designed to characterize MECL-1-deficient mice, we observed that in contrast to WT T cells, MECL-1 À/À T cells were unable to expand in lymphocytic choriomeningitis virus (LCMV)-WE infected mice [9] . These findCorrespondence: Prof. Marcus Groettrup e-mail: Marcus.Groettrup@uni-konstanz.de ings were in accordance with the previous experiments performed with LMP2 and LMP7 Â MECL-1 gene-targeted mice. After adoptive transfer of these T cells, followed by an influenza virus infection of the recipient WT mice, neither LMP2 À/À nor LMP7 À/À Â MECL-1 À/À T cells were able to expand to the same extent as C57BL/6 WT cells [7, 10] . As a possible explanation, the authors suggest rejection of donor T cells by the host immune response because of either reduced surface MHC expression by LMP7 À/À T cells [11] or differences in minor histocompatibility Ag (miHAg). However, it was never thoroughly investigated whether the attenuation of immunoproteasomedeficient T cells in virus infected mice was indeed an artifact of the T-cell transfer experiment based on a host versus graft reaction or whether a so far unknown function of immunoproteasome subunits for T-cell survival or expansion could underlie this phenomenon. An independent hint that immunoproteasome subunits may play a so far unappreciated role for T-cell differentiation and/or expansion were the 20-30% reduced number of CD8
1 as compared with CD4 1 T cells in lymphoid organs of LMP2 À/À [12] and MECL-1 À/À [9] mice. Reconstitution experiments of irradiated WT mice with BM from WT and LMP7 À/À MECL-1 À/À mice showed that the lower CD8
1

/CD4
1 ratio remained among the LMP7/MECL-1 double-deficient T cells although they were selected in the same thymus of recipient mice as WT cells with a normal CD8 1 /CD4 1 ratio. This result indicated that the selective reduction of CD8 1 T cells lacking LMP7 and MECL-1 was a T-cell intrinsic phenomenon not related to altered Ag presentation in the thymus [13] .
In this study, we show that a functional requirement for immunoproteasome subunits rather than graft rejection accounts for the loss of LMP2 
Results
Immunoproteasome-deficient T cells cannot compete with WT T cells of virus-infected mice
To investigate the proliferative performance of immunoproteasome-deficient T cells elicited by an LCMV-WE infection in a WT environment, we adoptively transferred MECL-1
-or C57BL/6-T cells (all of them carrying the Thy1.2 marker) into LCMV-WE-infected Thy1.1 recipient mice. Eight days post-infection, C57BL/6-derived donor T cells proliferated to an extent of 2.5570.03% of total lymphocytes, whereas mice that received LMP2 À/À T cells comprised only 1.2970.07%
donor T cells. In mice having received MECL-1 À/À T cells, we could hardly detect any donor cells on day 8 after infection (0.5470.17% of total lymphocytes) and a similar loss of the graft was observed for mice which had received LMP7 À/À T cells (0.1870.03%) ( Fig. 1A and B) .
To document the kinetics of donor T-cell expansion, we injected naïve MECL-1 À/À or C57BL/6 control T cells into LCMV-WE-infected WT mice and analyzed the presence of donor T cells in blood on several days after transfer ( Fig. 1C and D) . Since the endogenous LCMV-specific T cells of the host mouse also received an activation stimulus by the viral infection, the percentage of C57BL/6 WT donor T cells diminished in face of a vigorously expanding host population from day 5 (1.39%) to day 8 (0.5%), when 3 Â 10 7 T cells were transferred (Fig. 1C) . Briefly, 7 Â 10 7 -injected T cells (Fig. 1D) [14] and, to quote a second well-studied miHAg, 40-75% of male hematopoetic cell grafts survive in female recipients at day 10 after transfer [15] . As we are injecting only T cells but no professional APC, we assume that the rejection process would take even longer. But, as shown in Fig. 1 Fig. 3A ).
Being aware of the possibility that LMP7 gene-targeted T cells might be rejected by NK cells due to a diminished MHC expression [11] , we injected T cells of LMP7 À/À or C57BL/6 mice into Thy1.1 mice that were either LCMV-WE infected or remained naïve. Nine days after transfer, the LMP7 À/À T cells were hardly detectable in the virus-infected mice, but comparable numbers of WT (1.025% cells) and gene-targeted (0.815% cells) T cells were found in the naïve animals (Supporting Information Fig. 3B ). In a further approach to exclude rejection phenomena, we adoptively transferred T cells derived from LMP2 À/À , LMP7
À/À , MECL-1 À/À and C57BL/6 mice into different naïve Thy1.1 mice and monitored their persistence in blood on day 2 and day 10 and in spleen on day 22 after transfer. There were no statistically significant differences between the various donor T cells on day 2 or day 10, but we noted a reduction in particular of LMP2-deficient donor T cells in spleen 22 days after transfer (Supporting Information Fig. 3C ). Whether this was due to rejection of donor cells or failures in homeostatic proliferation or deregulation of some protein factor controlled by the function of immunoproteasomes has not yet been investigated. In order to directly compare the loss of LMP7 gene-targeted T cells in an LCMV-WE-infected recipient mouse to rejection processes due to miHAg, we injected a 1:1 mixture of female LMP7 À/À T cells and female or male Thy1.1 WT T cells into naïve or LCMV-WE-infected female CD45.1 congenic mice. The sexchromosome encoded HY-Ag of the male Thy1.1 WT donor cells are recognized as foreign in the female recipients and will eventually induce a T-cell response resulting in the rejection of the male T cells [15] . Mice were bled on day 1 and day 4 after number, but were still present at similar levels after 4 and 8 days ( Fig. 2D and F) . However, in LCMV-WE-infected host mice, LMP7-deficient T cells were substantially decreased already on day 4 and hardly detectable on day 8 after transfer. On the contrary, the percentages of Thy1.1 WT donor T cells in the same recipient mice were maintained from day 1 to day 8 after transfer, regardless of the gender of the T cells and thus regardless of the presence or absence of HY miHAg ( Fig. 2E and G). Taken together, these data indicate that the inability of LMP7 genetargeted T cells to survive in an LCMV-WE-infected recipient is unrelated to miHAg-induced rejection processes.
In an attempt to better define the reason why immunoproteasome-deficient T cells cannot survive in the LCMV-infected host, we monitored the expression of a panel of cluster of differentiation molecules on different hematopoetic cells and at different time points of the antiviral immune response to identify potential deregulations regarding homeostatic proliferation, homing to peripheral lymphoid organs, activation, migration to the source of infection or apoptosis. In none of the analyzed tissues and at no time point, significant differences in the expression of the indicated marker molecules between C57BL/6 WT and immunoproteasome deficient mice were detectable (Supporting Information Table 1 ).
Unaltered homeostatic and mitogen-induced T-cell expansion
Next, we investigated whether the homeostatic expansion of MECL-1, LMP2 and LMP7 single knockout T cells was disturbed.
To this aim, we monitored the reconstitution of the T-cell repertoire in RAG-2-deficient mice, after injection of a 1:1 mixture of WT (Thy1. well as during mixed lymphocyte reactions [16] . To address the mitogen-induced T-cell expansion, we stimulated CFSE-labeled splenic T cells from LMP7 À/À Â MECL-1 À/À mice, for 48 h (data not shown), 72 and 96 h (data not shown) in vitro with either plate-bound anti-CD3/CD28 (Supporting Information Fig. 5A ) or PMA/ionomycin (Supporting Information Fig. 5B ). Neither CD4
hyperproliferation at any time point and activating signal used. In accordance with this, in mixed BM chimeric mice it was shown that LMP7 À/À Â MECL-1 À/À T cells expanded to the same extent as immunoproteasome-expressing T cells in response to bacterial infections [13] . A mitogen-induced hyperproliferation is therefore unlikely to be the underlying mechanism why T cells lacking single immunoproteasome subunits do not persist in the LCMVinfected host.
Expansion of T cells in Listeria monocytogenes-or vaccinia virus-infected host mice
To examine whether we are facing a pathogen-specific effect, we also transferred T cells of the different immunoproteasome subunit deficient and WT mice in naïve Thy1.1 mice that were either infected with vaccinia Virus (VV-WR) or with recombinant Listeria monocytogenes expressing OVA (rLM-OVA). There were no differences in T-cell expansion between the different mouse strains in rLM-OVA-infected recipient mice (Supporting Information Fig. 6C ) and only slightly reduced numbers of LMP2 À/À (0.5970.06%), Fig. 6B ).
Both LMP7-deficient CD8 determined. In the absence of LCMV infection, the numbers of cells lacking or expressing LMP7 were equal for all cell types analyzed (Fig. 3A) . On the contrary, in LCMV-WE-infected host mice, the percentage of LMP7 À/À cells was markedly reduced compared with C57BL/6 cells with CD4 (Fig. 5A and B) . If the recipient mice were left uninfected, the different donor genotype-derived cells did not differ in the percentage of apoptotic cells 16 and 40 h after transfer (Fig. 5A-D) and the same was true for all donor cells analyzed in LCMV-WEinfected recipients 40 h after transfer. LCMV-WE-infected and naïve host cells and the corresponding donor TCRtg CD8 1 T cells were analyzed for the expression of a panel of cluster of differentiation molecules known to be involved in T-cell activation, migration, downregulation and homeostasis. However, immunoproteasome compromised donor T cells displayed no altered expression levels for any of the listed molecules compared with WT donor T cells (Supporting Information Table 2 ). In summary, only TCRtg donor cells in infected host mice displayed enhanced levels of apoptotic cells at very early time points, leading to the presumption that either the TCR stimulation or the cytokine storm induced by the high quantity of LCMV-specific donor cells deliver signals which can only be accommodated in the presence of functional immunoproteasomes very early after infection.
Discussion
Mice lacking the immunoproteasome subunits LMP2, LMP7 and MECL-1 are known to have mild phenotypes. Although clear WT host that a deficiency of these cells to expand and survive was noted [7, 9] . Recently, Hensley et al. observed a partial loss of transferred LMP2 À/À cells even in naïve mice [18] . A trivial explanation for the loss of transferred immunoproteasomedeficient cells would be that the transferred cells were specifically recognized and rejected by host T cells. In this study, we investigated the fate of immunoproteasome-deficient CD4 1 and CD8 1 T cells in LCMV-infected mice and came to the conclusion that the rapid loss of these cells cannot be attributed to graft rejection but that it identifies the requirement for immunoproteasomes for the persistence of leukocytes in an LCMV-infected mouse in which WT recipient cells mount a fulminant innate as well as adaptive CTL response associated with a vigorous storm of proinflammatory cytokines. Several observations argue against the possibility of a differential homing or graft rejection phenomenon. First, the loss of immunoproteasome-compromised T cells was not limited to T lymphocytes in the spleen but was also confirmed in blood, peritoneum and different LN and hence excluding homing failures of LMP7 and MECL-1-deficient T cells (Supporting Information Fig. 2) . Second, the rejection of transferred LMP7 T cells survived to the same extent as C57BL/6 cells up to day 10 after transfer in naïve recipients (Supporting Information Fig. 3) . Nevertheless, LCMV acts as a potent activator of NK cells, but LMP2-and MECL-1-deficient T cells suffer from impaired expansion after transfer into LCMV-WE-infected recipients as well (Fig. 1B) although they are known to express normal MHC class I surface levels [9, 12] . Third, the transfer of CD8 1 T cells and B220 1 B cells into the same LCMV-infected mouse led to the complete disappearance of CD8 1 T cells, whereas the B cells persisted (Fig. 3C) . As B cells expressed the same (H-2K b ) or slightly higher (H-2D b ) levels of MHC class I molecules on the cell surface, this experiment rules out that differences in the peptide repertoire presented on class I proteins by LMP7-deficient andproficient cells are causing a rejection within 8 days after transfer. Finally, the cotransfer of T cells from male WT and female LMP7 À/À donor mice into female recipients showed the loss of LMP7 À/À T cells by day 4, whereas the T cells expressing HY miHAg persisted for 8 days (Fig. 2 ). An obvious question raised by our findings is toward the mechanism how immunoproteasomes may be involved in the control of T-cell expansion. We have recently observed that the treatment of mouse splenocytes with an LMP7-specific inhibitor reduces the production of IL-6 after LPS stimulation and the production of IFN-after anti CD3/CD28 stimulation [19] . The same effects were not observed with splenocytes from LMP7 À/À mice but we did find an enhanced IL-4 production by LMP7
À/À cells after stimulation with anti CD3mAb (Basler, M., Kalim, K., Groettrup M., unpublished data). It is hence possible that a deregulated cytokine profile in immunoproteasome-deficient cells causes the loss of these cells in an LCMV-infected WT mouse.
Another link between immunoproteasomes and the propensity of cells to undergo apoptosis has been proposed to rely on NF-kB processing. A link to immunoproteasomes was first provided by a publication reporting that a lack of LMP2 in NOD mice leads to reduced processing of NF-kB p105-p50 [20] but two laboratories refuted this notion shortly after publication [21, 22] . Very recently, however, Yewdell and colleagues found a minor reduction in the extent of IkB degradation, following the stimulation of LMP2 À/À B cells with LPS in vitro [18] . We have ourselves monitored p105, p50 and IkB levels in LMP2 À/À ,
LMP7
À/À MECL-1 À/À and WT T cells after stimulation with anti CD3 or TNF-and failed to find significant differences compared with WT controls (data not shown). Nevertheless, the limited proteolysis of p105-p50 by the constitutive proteasome is well documented [23] , and it could be possible that immunoproteasomes selectively process another factor which may be required for T-cell expansion and survival. Initial functional and phenotypic analyses of immunoproteasome-deficient mice were rather disappointing (discussed in [2] ). Infection of the knockout mice with LCMV induced a strong virusspecific CTL response that eliminated the virus comparable to WT mice [24] . No defect in T-cell proliferation could be observed in these mice. Therefore, it is intriguing that a reduced expansion and survival of immunoproteasome-deficient T cells becomes only apparent after adoptive transfer into an infected WT host. It seems that the requirement for immunoproteasomes for the expansion and survival of T cells is critical under certain circumstances. Indeed, in mouse models of rheumatoid arthritis [19] and colitis [25] , the lack of a functional immunoproteasome subunit protected mice from autoimmune diseases. Therefore, the data provided in this manuscript support the conception of the immunoproteasome as a potential new target for the suppression of undesired proinflammatory T-cell responses.
Materials and methods
Mice, viruses, bacteria, cells and media /BoyJ (also referred to as ''CD45.1-'' or ''Ly5.1 congenic mice'') were originally obtained from Charles River, Germany. B6.PL (Thy1.1) mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). MECL-1 [9] , LMP2 [12] and LMP7 [11] gene-targeted mice were kindly provided by Dr. John J. Monaco (Department of Molecular Genetics, Cincinnati Medical Center, Cincinnati, OH, USA); these mice have been bred onto the C57BL/6 background for at least ten generations. TCRtg P14 mice (tg line 318) [26] , specific for aa 33-41 ( 5 gp33 epitope, presented on MHC I) of the LCMV glycoprotein were obtained from Dr. Oliver Planz, Tübingen University. RAG-2-deficient mice bred onto C57BL/6 background were originally obtained from The Jackson Laboratory and bred in individually ventilated cages. Mice were kept in a specific pathogen-free facility and used at 6-12 wk of age. Experimental groups were age and sex matched and the review board of Regierungspräsidium Freiburg has approved experiments.
LCMV-WE was originally obtained from F. Lehmann-Grube (Heinrich Pette Institute, Hamburg, Germany) and propagated on the fibroblast line L929. VV-WR was obtained from Professor Hans Hengartner, University Hospital Zurich, Switzerland. The virus was propagated on BSC 40 cells. Mice were infected with 200 PFU or 2 Â 10 4 PFU LCMV-WE i.v. or with 2 Â 10 6 PFU VV-WR i.p. BSC 40 is an African green monkey kidney-derived cell line. All cells were grown in MEM 5% FCS. rLM-OVA was kindly provided by Professor Dirk Busch, Technische Universität München, Munich, Germany. The injection cultures were prepared by inoculation of 10 mL Brain-Heart Infusion Broth with 100 mL of the frozen (À701C) stock culture. After growing overnight on a shaker at 371C, the Listeria titer in the culture was estimated by spectrophotometry: 1 OD 600 nm unit 5 10 9 cfu/mL. The mice were immunised with 2 Â 10 4 CFU rLM-OVA in 200 mL PBS i.v. To quantify the injection dose, estimated by spectrophotometry, 100 mL of tenfold dilutions of the injection culture were plated on agar plates made of Brain-Heart Agar. Briefly, 24 h after incubation at 371C, the injection dose was determined by counting the colonies that were growing. All media were purchased from Invitrogen-Life Technologies; Karlsruhe, Germany, supplemented with GlutaMAX, 5 or 10% FCS and 100 U/mL penicillin/streptomycin.
T-cell isolation and adoptive T-cell transfer
T cells from splenocytes of naïve Thy1. 
CFSE labeling
In brief, 5 Â 10 7 cells were incubated in 1 mL of 10 mM 5 (6) 
Statistical analysis
To statistically assess differences between groups, Student's unpaired t-test was performed using the GraphPad software. A p-valueo0.05 was considered statistically significant for all analyses.
